We all know how much venture capital and other funding is being dumped into mobile this and mobile that for health care. What continues to be very unclear is whether any of these will do anything to improve health care delivery and outcomes, or whether they might even worsen those. Apps are being floated out there without almost no regulation and the quality of some has to be suspect. An article in Diabetes Care reviews a number of mobile apps intended to help patients manage diabetes care. (App Article) About 30 million Americans have diabetes. Over 75% of adults have a smartphone and according to research, 50% of those adults use the smartphone to do health-related tasks. The utility of mobile health apps has become a serious enough concern that people have actually developed a Mobile App Rating Scale to evaluate their quality. This scale looks at engagement, functionality, aesthetics and information. The authors of this article selected the top 30 of each of diabetes and diabetes management apps from the iTunes Store and from Google Play. After removing duplicates and other winnowing, they ended up with 89 apps. In addition to using the MARS tool, they looked at specific diabetes management tasks facilitated by the app. The top possible score is 6. The apps averaged a rating 3.79 for functionality, 3.43 for aesthetics (irrelevant), 3.15 for engagement, 2.23 for information and 2.99 for total quality. Only four of the apps integrated all diabetes management tasks identified by the reviewers and less than half had even four of the tasks. There were a couple of apps that had very high scores, but from the averages you can see that most of them aren’t particularly good. To the extent that patients might buy the hype and think that a mobile app is going to make a big difference in their health, they are likely being deluded. Similarly, physicians who hope that a mobile app may be a useful adjunct to their treatment recommendations are similarly likely to be disappointed.
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Subscribe to Blog via Email
As is usually the case in health care, the big just keep getting bigger. UnitedHealth Group’s Optum division is buying NaviHealth, which helps manage post-acute care for Medicare Advantage members.
May 20, 2020
Stellar Health shines as it raises $10 million in new financing for its business of aiding providers and payers in doing value-based care.
May 14, 2020
Another typical post. For new readers, this blog usually is all health care business, policy, and research and one staple is me making fun of the ridiculous names people put...
May 7, 2020
MedPAC 2019 Report to Congress
June 18, 2019